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sorLA is a recently identified neuronal receptor for amyloid precursor protein (APP) that is known to interact with APP and affect its
intracellular transport and processing. Decreased levels of sorLA in the brain of Alzheimer’s disease (AD) patients and elevated levels of
amyloid- peptide (A) in sorLA-deficient mice point to the importance of the receptor in this neurodegenerative disorder. We analyzed
APP cleavage in an APP-shedding assay and found that both sorLA and, surprisingly, a sorLA tail construct inhibited APP cleavage in a
-site APP-cleaving enzyme (BACE)-dependent manner. In line with this finding, sorLA and the sorLA tail significantly reduced secreted
A levels when BACE was overexpressed, suggesting that sorLA influences -cleavage. To understand the effect of sorLA on APP cleavage
by BACE, we analyzed whether sorLA interacts with APP and/or BACE. Because both full-length sorLA and sorLA C-terminal tail
constructs were functionally relevant for APP processing, we analyzed sorLA–APP for a potential cytoplasmatic interaction domain.
sorLA and C99 coimmunoprecipitated, pointing toward the existence of a new cytoplasmatic interaction site between sorLA and APP.
Moreover, sorLA and BACE also coimmunoprecipitate. Thus, sorLA interacts both with BACE and APP and might therefore directly affect
BACE–APP complex formation. To test whether sorLA impacts BACE–APP interactions, we used a fluorescence resonance energy
transfer assay to evaluate BACE–APP interactions in cells. We discovered that sorLA significantly reduced BACE–APP interactions in
Golgi. We postulate that sorLA acts as a trafficking receptor that prevents BACE–APP interactions and hence BACE cleavage of APP.
Key words: sorLA; Alzheimer’s disease; amyloid-; BACE; amyloid precursor protein; LR11
Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder with
neurofibrillary tangles and amyloid plaques as its pathological
hallmarks (Selkoe, 2001). Amyloid plaques are mainly composed
of aggregated amyloid- peptide (A), which is derived from the
amyloid precursor protein (APP) by sequential proteolysis by
-secretase -site of APP-cleaving enzyme (BACE) and preseni-
lin 1 (PS1) (Hussain et al., 1999; Sinha et al., 1999; Vassar et al.,
1999; Wolfe et al., 1999; Yan et al., 1999; Lin et al., 2000; Xia et al.,
2000; Wolfe and Kopan, 2004). In recent studies, sorLA/LR11, a
highly conserved type I membrane receptor, has been identified
that impacts APP processing (Andersen et al., 2005). Overexpres-
sion of sorLA in neurons shifts the subcellular localization of APP
to the Golgi apparatus and reduces the production of secreted
A. The pathogenic relevance of sorLA in Alzheimer’s disease is
demonstrated by elevated levels of A in sorLA-deficient mice
(Andersen et al., 2005) and by the reduced expression of sorLA in
the brain of AD patients (Scherzer et al., 2004; Andersen et al.,
2005).
sorLA is a member of a novel family of vacuolar protein sort-
ing 10 protein (Vps10p) receptors, which contain a domain with
high homology to the yeast-sorting protein Vps10p (Yamazaki et
al., 1996; Jacobsen et al., 2001). The 54-residue cytoplasmatic
domain is highly similar to that of the cation-independent man-
nose 6-phosphate receptor and is also capable of binding Golgi
apparatus-localized -ear-containing ARF-binding (GGA) pro-
teins (Jacobsen et al., 2002). Because the Vps10p domain and the
interaction of GGA adaptor proteins with the mannose
6-phosphate receptor have been shown to mediate intracellular
protein trafficking (Puertollano et al., 2001; Takatsu et al., 2001;
Zhu et al., 2001), it is plausible that sorLA is a sorting receptor
involved in APP trafficking and processing in neurons. In line
with these structural features of sorLA, the receptor mainly af-
fects trafficking and processing rather than the synthesis of APP
(Andersen et al., 2005). Overexpression of sorLA in neuronal
SY5Y cells leads to a decrease in cell surface APP and coincides
with significantly lower production of sAPP, sAPP, and A
compared with wild-type cells. Overexpression of a mutant form
of the receptor lacking the sorLA cytoplasmatic domain not only
points to a role of sorLA in APP trafficking but also demonstrates
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that the lumenal N-terminal parts of sorLA and APP interact; this
was confirmed by surface plasmon resonance analysis (Andersen
et al., 2005).
sorLA could act as an endocytic receptor for APP, enhancing
APP turnover or directing APP to non-A-generating degrada-
tion pathways. Alternatively, sorLA could also impact APP traf-
ficking or access to BACE or -secretase, precluding A genera-
tion. In the present study, we observe a second site of interaction
between APP and sorLA involving the C-terminal domains of
APP and sorLA. Moreover, we show that the sorLA tail alone is
sufficient to influence APP processing and provide additional
evidence that sorLA influences the production of sAPP and A.
Surprisingly, we found that sorLA also interacts with BACE. Our
results suggest that sorLA acts as a crucial regulatory molecule for
BACE–APP interactions.
Materials and Methods
Generation of expression constructs. The generation of sorLA (human
cDNA in pcDNA3.1), C-terminal myc-tagged APP695 (APP-myc), C99
(C99-myc), secreted alkaline phosphatase (SEAP) fused to the N termi-
nus of APP695 (SEAP–APP) and C-terminal V5-tagged BACE (BACE–
V5) constructs was performed as described previously (Kinoshita et al.,
2001; Lichtenthaler et al., 2003; von Arnim et al., 2004; Andersen et al.,
2005). The sorLA tail construct that encodes bp 6355– 6442, according to
GenBank accession number NM_003105, was amplified and ligated into
expression vector pSecTag2B (Invitrogen, Carlsbad, CA) by PCR using the
following primers: 5-CCGCTCGAGTCTGGGGTCTGGTGCAGATG-
CA-3 and 5-CGTCTAGAGGCTATCACCATGGGGACGTC-3.
The PCR product was inserted into the XhoI/XbaI restriction sites of
modified pSecTag.
To generate the C-terminal green fluorescent protein (GFP)-tagged or
flag-tagged construct for sorLA, the sorLA pcDNA3.1 construct was
modified using the QuickChange site-directed mutagenesis kit (Strat-
agene, La Jolla, CA) to insert an AgeI restriction site. GFP was amplified
by PCR and inserted into the new C-terminal AgeI site using the primer
pair: 5-CTAACCGGTATGGTGAGCAAGGGCGAGG-3 and 5-CT-
AACCGGTTTACTTGTACAGCTCGTCCATGC-3.
C-terminal flag-tagged sorLA was generated with a linker sequence
using the primer pair: 5-CCGGTGATTACAAGGATGACGA-
CGATAAGTGAA-3 and 5-CCGGTTCACTTATCGTCGTCATCCT-
TGTAATCA-3.
The GYENPTY site mutant of C99 was generated by substitution of the
tyrosine residues 86 and 91 (of C99) to alanine of C99-myc using the
QuickChange site-directed mutagenesis kit (Stratagene). Authenticity of
all PCR products and the PCR-generated constructs was confirmed by
DNA sequencing.
Cell culture conditions and transient transfection. For this study, we
used Chinese hamster ovary (CHO) 7W (Wolfe et al., 1999), mouse
neuroblastoma N2a cells and human embryonic kidney 293 (HEK293)
cells. CHO 7W and N2a cells were grown in OptiMEM (Invitrogen) with
5% FBS and HEK293 cells were grown in DMEM with 10% FBS in an
incubator at 37C and 5% CO2. Transient transfection of the cells was
performed using a lipid-based method (FuGENE 6; Roche Applied Sci-
ence, Indianapolis, IN) according to the instructions of the
manufacturer.
Primary neuronal cultures were generated from CD1 mice at embry-
onic day 15–16, as described previously (Berezovska et al., 2003). Hip-
pocampal and cortical neurons were dispersed in neurobasal media
(Invitrogen) containing 10% FBS and plated onto poly-L-lysine coated
four-well glass slides. The media was exchanged after 1 h to neurobasal
media containing 1 B27, in which the cells were cultured for 10 –12 d in
vitro.
Immunocytochemistry. Immunostaining was performed 24 h after
transient transfection. Cells were fixed in 4% paraformaldehyde for 10
min, washed in Tris-buffered saline (TBS), pH 7.3, permeabilized with
0.5% Triton X-100 for 20 min, and blocked with 1.5% normal goat serum
for 1 h. To detect the localization of APP695-myc or C99-myc and sorLA,
transfected cells were immunostained using monoclonal antibody 8E5
(raised against 444 –592 residues of APP770; a gift from Elan Pharma-
ceuticals, San Francisco, CA) and rabbit N-terminal anti-SOL-sorLA an-
tibody (1:2000) or N-terminal rab LA sorLA antibody (provided by
Anders Nykjaer, University of Aarhus, Aarhus, Denmark) or monoclonal
13G8 antibody (raised against 676 – 695 residues of APP770; 1:500; gift
from Elan Pharmaceuticals), monoclonal 9E10 anti-c-myc antibody
(Abcam, Cambridge, UK) and rab C-terminal anti-sorLA (raised against
20 C-terminal residues of sorLA; provided by Claus Munck Petersen,
University of Aarhus, Aarhus, Denmark). To detect the subcellular local-
ization of BACE, cells transfected with BACE–V5 were immunostained
with anti-V5 monoclonal antibody (Sigma, St. Louis, MO). Endogenous
BACE was stained or immunporecipitated by rabbit anti-BACE
N-terminal antibody (Calbiochem, La Jolla, CA). After three washes in
TBS, Alexa 488- and cyanine 3 (Cy3)-conjugated secondary antibodies
[from Invitrogen and Jackson ImmunoResearch (West Grove, PA)] were
applied for 1 h at room temperature. Immunostained cells were cover-
slipped using GVA (glycerol vinyl alcohol) mounting solution (Zymed,
South San Francisco, CA) before fluorescence lifetime imaging micros-
copy (FLIM) measurements or confocal imaging with appropriate filters
using a Bio-Rad (Hercules, CA) 1024 confocal microscope.
Fluorescence resonance energy transfer measurements using FLIM. We
applied a validated FLIM technique to quantitate protein–protein inter-
actions using multiphoton microscopy (Bacskai et al., 2003; Berezovska
et al., 2003). Images were acquired using a Bio-Rad Radiance 2000 mul-
tiphoton microscope. A mode-locked Ti:sapphire laser (Spectra Physics,
San Jose, CA) sends a 100 fs pulse every 12 ns to excite the fluorophore.
We used a high-speed Hamamatsu (Shizuoka, Japan) MCP5900 detector
and hardware/software from Becker and Hickl (Berlin, Germany) to
measure fluorescence lifetimes on a pixel-by-pixel basis. Excitation at
800 nm was empirically determined to excite Alexa 488 but not Cy3.
Donor fluorophore (A488) lifetimes were fit to two exponential decay
curves to calculate the fraction of fluorophores within each pixel that
interacts with an acceptor. As a negative control, Alexa 488 lifetime was
measured in the absence of acceptor (Cy3), which was equivalent to
Alexa 488 alone or in solution. Statistical analysis of FLIM data were
performed by Student’s t test after determination of normal distribution
and variance.
Western blotting. N2a or HEK cells were transfected with APP695-myc,
either empty vector or BACE-V5 and sorLA. For cell lysis, cells were
treated with 1% Triton X-100 using Complete Protease Inhibitor (Roche
Applied Science) and then loaded onto 4 –20% Tris-glycine polyacryl-
amide gels for separation under reducing and denaturating conditions.
After gel separation, proteins were transferred to polyvinylidene difluo-
ride (PVDF) membranes and labeled using IR700 and IR800 secondary
antibodies (Rockland, Gilbertsville, PA). Proteins were visualized on a
LI-COR (Lincoln, NE) Odyssey infrared detection system according to
the instructions of the manufacturer.
Immunoprecipitation. Immunoprecipitation of either myc-tagged C99
or GFP-tagged sorLA were performed with MACS epitope isolation kit
(Miltenyi Biotec, Auburn, CA) as recommended by the manufacturers.
The magnetic beads were precoupled to either anti-myc or anti-GFP
antibodies and were incubated with lysates for 30 min on ice. The com-
plex consisting of beads and proteins was captured on a flow-through
magnetic column and washed five times with cold lysis buffer. The pro-
teins then were eluted with hot elution buffer. For negative controls,
lysates from cells without the myc- or GFP-tagged protein were used.
Lysates and immunoprecipitates were loaded onto 4 –20% Tris– glycine
polyacrylamide gels (Novex, San Diego, CA) under denaturating and
reducing conditions. The proteins were transferred to PVDF membranes
(Millipore, Bedford, MA) and blocked in 5% nonfat dried milk. sorLA
was detected by rabbit anti-SOL-sorLA antibody, and C99 was detected
by mouse 6E10 antibody (Signet, Dedham, MA). Secondary antibodies
conjugated to infrared dyes were applied and detected using the LI-COR
system.
Immunoprecipitation of BACE–V5 and sorLA were performed with
BioMag goat anti-mouse or goat anti-rabbit IgG magnetic beads (Per-
Septive Biosystems, Framingham, MA). N2a cells were cotransfected
with BACE–V5 and sorLA and lysed in 1% Triton X-100 buffer. Cell
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lysates were incubated with anti-V5 or anti-SOL–sorLA antibody-loaded
beads for 3 h at 4°C. For negative controls, beads were incubated with
lysate or antibody alone. After the incubation, beads were washed and
boiled in 2 Tris– glycine SDS sample buffer (Invitrogen). Supernatants
and immunoprecipitates were loaded onto 4 –20% Tris– glycine poly-
acrylamide gels (Novex) under denaturing conditions. Western blots
were performed as described above using anti-V5 and rabbit SOL–sorLA
antibody for detection.
Immunoprecipitation of endogenous sorLA by BACE was done with
Sepharose beads. Beads and mouse brain lysates were incubated with
anti-BACE Ab or PBS at 4°C. After the supernatants were collected, beads
were washed with 1% CHAPSO lysis buffer, boiled with 2 Tris– glycine
SDS sample buffer and loaded onto 4 –20% Tris– glycine polyacrylamide
gels (Novex) under denaturing and reducing conditions. The proteins
were transferred to PVDF membranes (Millipore), and sorLA was de-
tected by rabbit SOL–sorLA antibody or C-terminal anti-sorLA anti-
body. Secondary antibodies conjugated to horseradish peroxidase were
applied and visualized by chemiluminescence.
Internalizaion assay. CHO 7W (APP751 stable overexpressing cells,
provided by D. Selkoe, Brigham and Women’s Hospital, Boston, MA)
were cultured on six-well plates and transfected with sorLA or empty
vector pcDNA3.1. On the next day, cells were washed with cold PBS
containing 1 mM CaCl2 and 1 mM MgCl2, 0.2% BSA, and 5 mM glucose
and incubated for 30 min on ice with biotinylated 6E10 (Signet). Cells
were then incubated at 37°C for different times to allow for endocytosis
of 6E10. After endocytosis, surface biotin was masked using streptavidin
(Roche Applied Science) for 1 h on ice and quenched with 0.5 mg/ml
biocytin (Sigma). Cells were harvested in blocking buffer containing 1%
Triton X-100, 0.1% SDS, 0.2% BSA, 50 mM NaCl, 1 mM Tris, pH 7.4, and
incubated on IgG-coated 96-well plates at 4°C overnight. Plates were
washed with PBS and streptavidin–peroxidase (Roche Applied Science)
was applied for 1 h in blocking buffer. Finally, plates were washed and
then incubated with 10 mg of o-phenyldiamine HCl (Sigma), 10 l of
30% H2O2 in 25 ml of 50 mM Na2HPO4, 27 mM citrate, pH 5.0. The
readout was done at 490 nm to determine internalized APP against sur-
face APP.
APP ectodomain shedding assay. HEK293 cells cultured in 12-well
plates were transfected in triplicate with a -galactosidase (-gal) re-
porter, SEAP–APP and either BACE, sorLA, sorLA tail, or combinations
of either sorLA or sorLA tail with BACE. On the next day, media were
changed and collected after 24 h. SEAP activity in conditioned media was
determined by a chemiluminesscent assay (Roche Applied Science) and
normalized to -gal. The SEAP assay was done to according to the in-
structions of the manufacturer, and -gal activity was measured by hy-
drolysis of o-nitrophenylk-D-galactopyranoside in cells lysed with re-
porter lysis buffer (Promega, Madison, WI). To confirm consistent
expression of SEAP–APP, BACE, and sorLA constructs, Western blotting
was performed as described above.
A quantification. CHO 7W cells were transfected either with BACE,
sorLA, sorLA tail or a combination of BACE and sorLA constructs. For
A quantification in the media, media was exchanged after 24 h and
collected after another 24 h. A40 levels were determined by sandwich
ELISA using BNT77 (anti-A 11–28) as the capture antibody and horse-
radish peroxidase-linked BA27 as detection antibodies (Takeda Chemi-
cal Company, Osaka, Japan) (Fukumoto et al., 1999; Irizarry et al., 2004).
Purified A40 (Bachem, King of Prussia, PA) was used as standard. The
sensitivity of this ELISA assay is 1 pM A, and it is not affected by serum
and plasma proteins because of the high affinity of the antibodies
(Scheuner et al., 1996; Kosaka et al., 1997; Fukumoto et al., 2003). Cells
were checked for consistent expression of constructs using Western blot-
ting as described above.
Results
Endocytosis of APP by sorLA
In our previous study, we analyzed several aspects of the role of
the putative sorting receptor sorLA in APP metabolism. We
showed that overexpression of sorLA coincides with sequestra-
tion of APP in the Golgi and reduced cell surface exposure of APP
(Andersen et al., 2005). Conceivably, sequestration may be
achieved by sorLA-mediated retention of APP en route through
the secretory pathway to the plasma membrane or by accelerated
internalization of APP from the cell surface and recycling back to
the Golgi. To investigate whether sorLA may act as an endocytic
receptor mediating the internalization of cell surface APP, we
assayed the uptake of biotinylated cell surface APP over time (Fig.
1). In these experiments, we did not detect a difference between
sorLA-expressing and sorLA-deficient cells, because we observed
a relative uptake of APP 80% in both conditions. These data
indicate that sorLA activity does not influence APP uptake from
the cell surface but rather affects the kinetics of APP trafficking
through the Golgi.
APP shedding assay
Recently, we demonstrated that the sorLA overexpression causes
a significant reduction of sAPP, sAPP, and A levels
(Andersen et al., 2005) and that the extracellular domain of sorLA
binds directly to APP. To investigate the molecular mechanisms
that are responsible for reduced APP processing, we established
an APP shedding assay. Based on this assay, we were able to
analyze whether sorLA impacts BACE dependent APP cleavage.
Additionally, we asked whether the sorLA C-terminal tail alone
was sufficient to reduce APP cleavage. Therefore, we assessed
APP cleavage by transfecting HEK293 cells with an APP con-
struct, where a secreted alkaline phosphatase is fused to the
N-terminal end of APP695 (SEAP–APP). Whenever this con-
struct gets cleaved, the N-terminal fragment of APP is secreted
into the media, and the amount of alkaline phosphatase activity
in the media provides a sensitive indicator for sAPP production
(Lichtenthaler et al., 2003). HEK293 cells were transfected with
SEAP-APP and empty vector, BACE, sorLA–FLAG, sorLA-tail–
FLAG or both BACE and sorLA or sorLA-tail–FLAG. To normal-
ize for transfection efficiency, a -gal reporter construct was co-
transfected, and the resulting SEAP activity in the media was
normalized to -gal activity. The SEAP activity for cells overex-
pressing sorLA or sorLA tail only was unchanged in comparison
to the empty vector controls (Fig. 2A, lanes 1–3). However, when
BACE was overexpressed as well, sorLA strongly reduced SEAP–
APP cleavage by 50% in comparison to cells only transfected with
BACE (Fig. 2A, lane 5). This is consistent with our previous
findings (Andersen et al., 2005), in which sorLA inhibits sAPP
production particular in SH-SY5Y cells, a cell line with high en-
Figure 1. APP internalization assay shows that APP internalization is not dependent on
sorLA. 7W CHO cells were transfected with either empty vector or sorLA. The uptake of cell-
surface-biotinylated APP was assessed by determining internalized versus cell surface APP. The
internalization of APP is indicated in percentage of cell surface APP over 40 min and revealed no
sorLA-dependent uptake of APP. The results are representative of data of three independent
assays. The means and SD of one assay performed in triplicate are shown.
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dogenous BACE levels. Moreover, the sorLA-tail construct sig-
nificantly lowered SEAP activity as well, although less efficiently
than the full-length construct, which points toward a partial
function of the construct in reducing APP cleavage (Fig. 2A, lane
6). In addition, overexpression of sorLA did not alter cellular
levels of APP or BACE, suggesting that the effect is on APP–BACE
trafficking and interactions rather than synthesis or degradation
(Fig. 2C).
sorLA reduces secreted A40 dependent on BACE
The finding that sorLA and sorLA tail both reduce APP cleavage
in the presence of BACE suggests that sorLA impacts -cleavage.
We therefore hypothesized that sorLA also has a BACE-
dependent effect on A generation. As expected, BACE transfec-
tion leads to a significant increase in A production (Fig. 2B, lane
4). Cotransfection of sorLA or sorLA tail with BACE blocks this
increase and brings A back to baseline levels, suggesting that
sorLA has an important function in regulating APP–BACE inter-
actions (Fig. 2B, lanes 5 and 6). Interestingly, overexpression of
sorLA or sorLA tail, without BACE overexpression (Fig. 2B, lanes
2 and 3), did not lead to an observable reduction in baseline A
generation in CHO cells.
Colocalization of sorLA and C99
Based on the finding that sorLA tail alone was sufficient to reduce
APP cleavage and A generation, we investigated a potential sec-
ond interaction site between the C-terminal tails of sorLA and
APP. In our previous study, we demonstrated the interaction of
the N-terminal domains of APP and sorLA (Andersen et al.,
2005). To characterize a potential C-terminal interaction site be-
tween APP and sorLA, we analyzed whether C99, which lacks
most of the extracellular domain of APP, still colocalizes with
sorLA. To this end, sorLA and C99-myc-cotransfected N2a (Fig.
3A) or HEK (Fig. 3B) cells were immunostained with sorLA rab-
bit tail antibody, visualized by Alexa 488, and ms 13G8 anti-APP
C-terminal antibody labeled by Cy3. The double immunostain-
ing revealed colocalization mainly in the perinuclear region.
More distal compartments showed less congruent staining for
sorLA and C99. There was no difference in the staining pattern
between the individual overexpression of sorLA and C99 and the
coexpression of both proteins. This pattern of colocalization was
identical to that observed with sorLA and full-length APP.
Interaction of sorLA and C99 in pull-down experiments
To analyze whether sorLA and C99 bind to each other, extracts
from C99-myc and sorLA-transfected N2a cells were pulled
down with myc-binding beads and probed with rabbit anti-
sorLA and mouse 9E10 anti-myc antibody. C99 constructs were
used to investigate a specific C-terminal tail interaction, because
immunoprecipitation of full-length sorLA with APP might re-
flect the previously described N-terminal domain interaction.
Immunoreactive bands of 250 kDa for sorLA and 20 kDa for
C99 were detectable in the immunoprecipitated sample, demon-
strating that sorLA was pulled down by C99-myc (Fig. 4, lane 1).
To check for nonspecific interactions, individually transfected
lysates were probed, resulting in the absence of sorLA pull-down
by C99-myc only (Fig. 4, lane 2) or in cells only expressing sorLA
(Fig. 4, lane 3). Coimmunoprecipitation of sorLA by C99 was
confirmed when using lysates from sorLA–GFP- and C99-myc-
transfected cells and using GFP-binding beads. Cell extracts from
cells expressing either C99-myc or sorLA constructs show no
specific pull-down bands (data not shown).
Previous studies have shown that the GYENPTY motif in the
cytoplasmatic tail of APP is responsible for the binding of adaptor
proteins and seems to mediate endocytosis of APP via the adaptor
protein Fe65 and low-density lipoprotein receptor (LDLR)-
related protein (LRP) (Lai et al., 1995). The GYENPTY motif
includes the NPXY motif, which is the endocytosis motif in the
tail of the LDLR. To investigate whether the binding of C99 to
sorLA is dependent on the GYENPTY motif, a mutant construct
of C99 was used, in which tyrosine residues were mutated to
alanine residues. Remarkably, the C99GYENPTY-myc mutant
construct was also sufficient to pull down sorLA (Fig. 4, lane 4),
indicating a GYENPTY-motif-independent interaction of both
proteins. For both C99 wild-type and mutant form, the C99 pull-
down produced strong immunoreactive bands at 250 kDa, the
expected size of sorLA.
Figure 2. A, APP ectodomain shedding assay shows that APP cleavage is altered by sorLA.
HEK293 cells were transfected with SEAP–APP, -gal reporter construct, and empty vector (1,
4), sorLA (2, 5), or sorLA-tail (3, 6) constructs with or without BACE. SEAP–APP cleavage is
quantitated by alkaline phosphatase activity in conditioned media normalized to -gal activity.
The results are representative of data of three independent assays. The means and SD of one
assay performed in triplicate are shown. *p  0.05, Student’s t test. B, Production of secreted
A is dependent on sorLA. 7W CHO cells stably expressing APP were transfected with empty
vector (1), sorLA (2), sorLA-tail (3) construct, or BACE (4), BACE–sorLA (5), BACE–sorLA-tail (6).
The amount of secreted A40 was measured in triplicate by ELISA assay, and means and SD are
given. The experiment was performed in three independent assays (*p  0.05; Student’s t
test). C, Western blotting of sorLA, APP, and BACE. Cotransfection of APP– empty vector, APP–
sorLA, APP–BACE–V5, or APP–BACE–V5–sorLA revealed no influence of sorLA expression on
APP or BACE levels. Conditions were probed with 8E5 anti-APP, ms anti-V5, and sorLA antibody
as indicated by immunoreactive bands.
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Interaction of sorLA and C99 by FLIM
analysis in N2a cells
To further study the interaction of C99
and sorLA in intact cells and to determine
in which subcellular compartments both
proteins interact, we performed FLIM in
mouse neuronal N2a cells. FLIM is a new
fluorescence resonance energy transfer
(FRET)-based technique for detecting in-
termolecular or intramolecular interac-
tions that take place within a distance of 10
nm or less. The fluorescence lifetime is in-
fluenced by the surrounding environment
and shortened in the immediate vicinity of
a FRET acceptor fluorophore in propor-
tion to the distance between the fluoro-
phores (Berezovska et al., 2003).
First, we analyzed the proximity of the
intracellular domains of APP and sorLA by
FLIM. N2A cells were transfected with
APP695-myc and sorLA constructs and
were stained for the intracellular domain
of sorLA by the rabbit C-terminal sorLA
antibody labeled by Alexa 488 and for APP
by mouse 13G8 labeled by Cy3. The dou-
ble immunostaining showed colocalization of APP and sorLA in
perinuclear and distal compartments. For the FLIM analysis, the
change in the lifetime of the donor fluorophore Alexa 488 under
different experimental conditions was determined. As a negative
control, the lifetime of Alexa 488 attached to the C terminus of
sorLA was measured in the absence of acceptor (Cy3), which
showed lifetimes of 1985  20 ps, equivalent to Alexa 488 –IgG
alone (Fig. 5A). The lifetime was significantly shortened when
sorLA labeled by Alexa 488 was costained with Cy3-labeled
APP695 to 1844  123 ps, indicating FRET attributable to close
proximity between sorLA and APP695 (Fig. 5B). The degree of
lifetime shortening is displayed in a pseudo-color-coded image,
indicating shortening of lifetime in yellow and red, particularly in
the perinuclear region and some endosomal-like structures.
Equivalent results were obtained when the acceptor and donor
fluorophores were exchanged. In cells transfected with only APP,
in the absence of acceptor fluorophore (Cy3), lifetimes of 1962 
33 ps were detected. The lifetime was shortened to 1881  62 ps
when cells were coexpressed with sorLA that was labeled with Cy3
(n  12; p  0.001).
Although the C-terminal domains of APP695 and sorLA are in
close proximity, their interaction reflected by a shortening in
lifetime could be attributable to the interaction of the N-terminal
domains, moving the C-terminal domains closer together. To test
whether there is an N-terminal-independent interaction of the
C-terminal domains of APP and sorLA, FLIM analysis of the
proximity between sorLA and C99-myc, which lacks most of
the APP extracellular site, was performed. C99-myc and sorLA-
transfected N2a cells were stained by rabbit C-terminal sorLA
antibody labeled by Alexa 488 and for C99-myc by mouse anti-
myc 9E10 antibody, which was labeled by Cy3. The lifetime of
Alexa 488 attached to the C terminus of sorLA (1985  20 ps) was
dramatically shortened when cells coexpressed C99-myc, which
was labeled with Cy3, to 1712  131 ps (Fig. 5C, Table 1). To
verify the observation of the pull-down experiments, indicating
that sorLA binds C99 independent from the GYENPTY motif, we
analyzed the proximity of the C99GYENPTY-myc mutant con-
struct to sorLA. We measured a lifetime reduction to 1617  214
in sorLA–C99GYENPTY-myc-transfected cells, equivalent to
the results of C99 and sorLA interaction (Fig. 5D, Table 1).
Together, our FLIM results confirm the existence of a
GYENPTY-independent C-terminal binding site on sorLA that
allows for the interaction with the APP C terminus in addition to
the interaction domains located in the extracellular region of the
proteins (Andersen et al., 2005). Our findings furthermore show
that the interaction between sorLA and C99 occurs mainly in the
perinuclear region, most likely in the Golgi apparatus.
The sensitivity of the lifetime measurements to proximity is
illustrated by an additional negative control. Fluorophores lo-
cated in proteins on opposite sides of a membrane are usually
considered to be too far apart to show FRET. The lifetime of
sorLA labeled at the extracellular N terminus (rabbit anti-sorLA)
Figure 3. Localization of sorLA and C99 in transfected cells. A, B, sorLA and C99 were cotransfected into N2a cells (A) or HEK293
cells (B) and immunostained with anti-tail sorLA antibody visualized by Alexa 488 (green) and mouse 13G8 antibody labeled by
Cy3 (red). The panels on the right show colocalization of sorLA and C99 in yellow.
Figure 4. Coimmunoprecipitation of C99 and sorLA. C99-myc was pulled down by myc-
beads and probed for sorLA by LA–sorLA antibody (lane 1). N2a cells transfected with C99-myc
(lane 2) or transfected with sorLA only (lane 3), showed no nonspecific pull-down. Specific
coimmunoprecipitation of sorLA was also observed when immunoprecipitating transfected
C99GYENPTY-myc mutant construct (lane 4). For all experiments, specific bands for C99-myc
stained with 13G8 antibody or sorLA were shown from cell lysates and pull-down.
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in the presence of APP labeled at the intracellular C terminus with
mouse anti-APP antibody 13G8 labeled by Cy3 was determined
(Fig. 5E). The fact that in this control, Alexa 488 lifetime (1938 
45; n  9) is close to the negative control, demonstrates that
although sorLA and APP colocalize at the light level, the labeled
epitopes are too far apart to support FRET. This proves that a
change in the fluorescence lifetime, indicating FRET, is a more
sensitive measure of proximity than simple colocalization.
Interaction of sorLA and APP by FLIM analysis in
primary neurons
To examine the functional relevance of the interaction between
sorLA and APP, we furthermore investigated its presence in pri-
mary neurons on the level of endogenous protein by our N- and
C-terminal FLIM assay, respectively. Primary neurons were
stained for APP by N-terminal 8E5 antibody labeled with Alexa
488 and for sorLA by rabbit SOL–N-terminal antibody labeled
with Cy3. In the absence of an acceptor fluorophore, the donor
lifetime was 2167  21 (Fig. 6A, Table 2). The lifetime of Alexa
488 attached to the N terminus of APP was significantly short-
ened when cells were also stained for sorLA labeled with Cy3, to
1919  107 ps (Fig. 6B, Table 2), indicative of close proximity
between the two fluorophores. This was confirmed when the
acceptor and donor fluorophores were exchanged, because cells
stained for sorLA only showed a lifetime of 2059  18 ps, whereas
the lifetime was reduced to 1788  99 ps when APP was labeled
by Cy3 (data not shown; n  10; p  0.001). Because we previ-
ously identified the interaction of the C-terminal domains of
sorLA and APP in transfected cells, we labeled the sorLA C ter-
minus with Alexa 488 and the APP cytosolic tail with Cy3 on the
endogenous proteins. Again, we observed a significant shorten-
ing of the donor lifetime to 1985  47 ps (Fig. 6C, Table 2),
indicating that the C-terminal interaction between sorLA and
APP takes place on an endogenous level as well, consistent with
our observation that endogenous sorLA and APP can be coim-
munoprecipitated from neurons (Andersen et al., 2005). Our
data provide strong evidence for the physiological relevance of
the interaction between APP and sorLA and show that both pro-
teins come into close proximity in the perinuclear
compartments.
Coimmunoprecipitation of sorLA and BACE
When we analyzed APP cleavage in a shedding assay and mea-
sured secreted A, we found that both pathways were only inhib-
ited by sorLA when BACE is overexpressed. These results suggest
that sorLA impacts BACE activity. We therefore tested the hy-
pothesis that sorLA and BACE interact. Immunohistochemical
staining showed colocalization of both proteins in Golgi com-
partments, as expected from previous studies of BACE localiza-
tion (von Arnim et al., 2004). Therefore, we asked whether sorLA
might be able to interact not only with APP but also with BACE.
To analyze BACE–sorLA interactions, we immunoprecipitated
sorLA and probed with BACE antibody from cotransfected N2a
cells (Fig. 7A). In addition, the complementary coimmunopre-
cipitation was done, and immunoprecipitated BACE was probed
for sorLA (Fig. 7B). Both experiments showed immunoreactive
bands for sorLA at 250 kDa and double bands of 65 kDa in the
BACE pull-down or only a single band for BACE in the sorLA
pull-down, indicating interaction between sorLA and immature
BACE. BACE is present in cells in a partially glycosylated imma-
ture and a fully glycosylated mature form. The fact that, in the
sorLA pull-down, only the smaller immature BACE was coim-
munoprecipitated confirms our hypothesis that sorLA interacts
with BACE predominantly in the Golgi, in which immature
BACE resides. To test whether the interaction occurred with en-
dogenous levels of both proteins, we immunoprecipitated endog-
enous BACE from mouse brain tissue and looked for the coim-
munoprecipitation of sorLA by rabbit SOL–sorLA antibody.
Control precipitate from samples without BACE antibody
showed no immunoreactive bands for sorLA (Fig. 7D), whereas
sorLA detection from coimmunoprecipitate demonstrate an en-
dogenous interaction of sorLA and BACE (Fig. 7C). Thus, it is
Figure 5. FLIM analysis of sorLA APP and sorLA C99 interaction within N2a cells. A, For the
negative control, cells were transfected with sorLA and stained by C-terminal sorLA antibody
labeled by Alexa 488. The left panel shows confocal images of cells stained for sorLA by donor
fluorophore Alexa 488. The color-coded FLIM image highlights the lifetime of the donor fluoro-
phore in picoseconds. B, FLIM analysis of sorLA C terminus labeled by Alexa 488 and APP C
terminus labeled by Cy3-transfected cells demonstrate shortening of donor lifetime, particu-
larly in the perinuclear region. C, D, N2a cells cotransfected with sorLA, C99-myc (C), or
C99GYENPTY-myc mutant construct (D) were labeled on the cytoplasmatic domain by Alexa
488 or by Cy3. Shortening of lifetime appeared mainly in the perinuclear region as indicated by
red and orange colors in the pseudocolored image. E, Cells stained for the N-terminal domain of
sorLA by Alexa 488 and C-terminal domain of APP by Cy3 do not show a shortening of donor
fluorophore lifetime.
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possible that APP and BACE compete for
sorLA binding within the Golgi.
BACE–APP interaction is reduced
by sorLA
Our results demonstrated the interaction
of sorLA and BACE by coimmunoprecipi-
tation. In addition, we found that APP
cleavage and A production were only sig-
nificantly reduced in HEK293 and CHO
cells when BACE is overexpressed. Because
these findings suggest a direct impact of
sorLA on BACE–APP interaction, we in-
vestigated the subcellular distribution of
the interaction between BACE and APP in
the presence or absence of sorLA. To this end, we used a previ-
ously established FLIM assay in mouse neuronal N2a cells trans-
fected with BACE and APP in the presence and absence of sorLA.
BACE was stained with Alexa 488-labeled anti-N-terminal BACE
antibody and APP by Cy3-labeled 8E5 antibody. Immunostain-
ing showed a typical localization of BACE and APP in the endo-
plasmic reticulum (ER), Golgi and endosomal-like compart-
ments. As a negative control, lifetime of Alexa 488 attached to the
N terminus of BACE was determined in the absence of acceptor
(Cy3) and showed lifetimes of 2051  17 ps (Fig. 8A). When Cy3
was attached to the N-terminal domain of APP, we observed a
significant decrease in the lifetime to 1939  59 ps (Fig. 8B, Table
3). The interaction of BACE and APP was particularly strong in
the perinuclear region as indicated by red and orange colors in
the pseudocolored images. In contrast, the interaction of BACE
and APP was dramatically reduced when we analyzed FRET in the
presence of sorLA (Fig. 8C). The lifetime of Alexa 488 attached to
the N terminus of BACE was not significantly different from the
negative control (2027  28 ps), indicating that sorLA inhibits
the interaction of BACE with APP. Examination of the FLIM
images suggest that APP–BACE interaction was specifically dis-
rupted in the Golgi apparatus. These results suggest that sorLA
affected the interaction but not the subcellular distribution of
APP or BACE (Fig. 8, intensity images); both were present in the
Golgi, in which the presence of sorLA affected their close
association.
Discussion
The potential importance of SorLA in the pathophysiology of
Alzheimer’s disease is suggested by the observations that sorLA
expression is dramatically decreased in the brain of Alzheimer
patients and that sorLA null mice have accelerated amyloid pro-
duction (Scherzer et al., 2004; Andersen et al., 2005). In this
study, we demonstrate that the putative sorting receptor sorLA
has a complex set of interactions with APP and, surprisingly,
BACE. In addition to the previously described N-terminal inter-
action between sorLA and APP (Andersen et al., 2005), we iden-
tify a new functional C-terminal binding site on sorLA for APP.
sorLA overexpression reduces the -cleavage of APP and, in con-
sequence, also inhibits A generation. Our data suggest that
sorLA interacts with BACE in the Golgi, in which it appears to
directly inhibit BACE–APP complex formation and thereby re-
duces this component of BACE activity on APP. Thus, we find
two new interactions of sorLA: with the C terminus of APP and
with BACE, which may contribute to the mechanism how sorLA
influences APP metabolism and AD.
Recent studies have shown that the Vps10p receptor sorLA is
directly involved in the intracellular transport and processing of
APP (Andersen et al., 2005) and that the overexpression of sorLA
results in reduced cell surface APP and decreased levels of se-
creted sAPP and A. These results raised the question of whether
sorLA could mediate the internalization of cell surface APP and
thereby also reduce the processing of APP into sAPP and A. It
has been shown that sorLA is capable of mediating endocytosis
(Jacobsen et al., 2001) and binds apolipoprotein E-rich lipopro-
teins and mediate their uptake (Taira et al., 2001). When we
Table 1. FLIM assay for sorLA–APP and sorLA–C99 interaction in transfected N2a cells
Donor Acceptor
Lifetime (ps)
(mean  SD) n (cells)
Significance
(compared with control)
sorLA (Alexa 488) None 1985  20 12
sorLA (Alexa 488) C99-myc (Cy3) 1712  131 14 p  0.001
C99-myc (Alexa 488) None 2058  25 6
C99-myc (Alexa 488) sorLA (Cy3) 1527  269 8 p  0.001
sorLA (Alexa 488) None 1968  17 8
sorLA (Alexa 488) C99-myc (Cy3) 1575  239 9 p  0.001
sorLA (Alexa 488) None 1968  17 8
sorLA (Alexa 488) C99-NPXY myc (Cy3) 1633  259 11 p  0.001
sorLA (Alexa 488) None 2006  22 8
sorLA (Alexa 488) C99-NPXY myc (Cy3) 1617  214 8 p  0.001
Figure 6. FLIM analysis of APP and sorLA on endogenous proteins. A–C, Primary neurons
were immunostained for endogenous APP by N-terminal 8E5 antibody (A, B) or by C-terminal
13G8 antibody (C) labeled by Alexa 488 (A, B) or by Cy3 (C). The lifetime was measured in the
presence (B, C) or absence (A) of acceptor fluorophore Cy3 attached to the N terminus of endog-
enous sorLA (B) or C-terminal of endogenous APP (C). Pseudocolored FLIM images highlight
FRET between APP and sorLA in juxtanuclear and distal compartments (B, C).
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investigated uptake of APP from the cell surface, however, we
found that APP internalization is independent of sorLA. The
hypothesis that sorLA does not have a major function in endocy-
tosis is further supported by its low rate of endocytosis when
compared with other apoE receptors (Gliemann et al., 2004).
Thus, these data extend and support the concept that the reduced
level of APP on the cell surface in sorLA-overexpressing cells is
achieved by the retention of APP in the Golgi apparatus, rather
than an effect on cell surface uptake of APP.
To understand the role of sorLA in APP processing in detail,
we investigated the influence of sorLA on APP cleavage and A
generation. In addition to the observation that sorLA influenced
APP -cleavage, we uncovered a new interaction of the sorLA
cytoplasmatic tail in APP processing. Our results further indi-
cated a partial effect of the C-terminal sorLA tail on APP cleavage.
In line with these results, sorLA and sorLA tail also inhibit A
generation in an independent assay and different cell line. These
functional data suggested the existence of a
second C-terminal interaction site be-
tween sorLA and APP.
We recently demonstrated direct bind-
ing of the N-terminal domain of sorLA
and APP by surface plasmon resonance
analysis, analytical ultracentrifugation,
and cell culture experiments (Andersen et
al., 2005). Herein, we now report a second
binding site between the C-terminal do-
mains of sorLA and APP. We show that
sorLA coimmunoprecipitates with C99,
which lacks most of the extracellular do-
main of APP. Coexpression of sorLA and C99 showed that both
proteins predominantly reside in the Golgi apparatus and
endosomal-like compartments. When we used C99 mutation
construct of the GYENPTY motif, a motif in the C-terminal tail of
APP that has been suggested to mediate endocytosis of APP (Lai
et al., 1995), we observed that C99 and sorLA bind to each other
independently from the GYENPTY motif and bolster the obser-
vation that sorLA has no function in endocytosis of APP. More-
over, we used FLIM, a sensitive FRET-based technique (Ber-
ezovska et al., 2003), to analyze complex formation between
sorLA and C99. When we attached fluorophores to the
C-terminal tails of C99 and sorLA, we observed a strong FRET
signal in the perinuclear region and to a lower extent in distal
compartments. Our current data also support the presence of the
sorLA and APP interaction in intact neurons under physiological
conditions. Using FLIM analysis, on APP and sorLA in primary
neurons, we were able to show that the endogenous proteins
interact in the Golgi. This complements and extends our previous
observations that sorLA and APP can be coimmunoprecipitated
from neuronal cells (Andersen et al., 2005).
A striking result of our current study is the finding that APP
cleavage and A generation in CHO and HEK293 cells were only
reduced by sorLA when BACE, the -cleaving enzyme, was over-
expressed. Previous results in SY5Y cells with high endogenous
BACE levels have shown a sorLA-dependent reduction of sAPP
and A production without overexpressing BACE (Andersen et
al., 2005). Herein, we used cell lines with barely detectable BACE
levels and overexpressed BACE to highlight the relevance of
sorLA in BACE-dependent APP processing. Moreover, sorLA in-
teraction with APP and BACE was shown using endogenous lev-
els of protein, indicating that the results we describe are not a
consequence of protein overexpression.
We hypothesized that sorLA impacts a subset of APP–BACE
interactions and analyzed whether the sorLA effects could be
localized to a specific subcellular compartment. Several lines of
data are consistent with a predominant effect of sorLA on APP
and BACE in the Golgi. APP and BACE colocalize in the Golgi
apparatus and ER (Huse et al., 2000). The acidic pH optimum of
the -cleavage suggests that this step in APP processing predom-
inates within late Golgi apparatus compartments or endosomal
compartments (Sinha and Lieberburg, 1999; Sinha et al., 1999;
Vassar et al., 1999; Lin et al., 2000) and is consistent with previous
findings that -secretase cleavage occurs in all of these compart-
ments (Haass et al., 1992; Koo and Squazzo, 1994; Koo et al.,
1996; Perez et al., 1996).
sorLA is strongly expressed in the Golgi, in which it appears to
interact with APP, as suggested by both FLIM studies and the
observation that sorLA and APP are mainly colocalized in the
same subcellular fraction containing markers of the cis-Golgi
(Andersen et al., 2005). Moreover, our FLIM studies suggest that
Table 2. APP sorLA FLIM analysis on endogenous proteins in primary neurons
Donor Acceptor
Lifetime (ps)
(mean  SD) n (cells)
Significance
(compared with control)
APP-N (Alexa488) None 2167  21 12
APP-N (Alexa488) sorLA-N (Cy3) 1919  107 14 p  0.001
APP-N (Alexa488) None 2230  15 6
APP-N (Alexa488) sorLA-N (Cy3) 2136  42 8 p  0.001
sorLA-N (Alexa488) None 2059  18 6
sorLA-N (Alexa488) APP-N (Cy3) 1788  99 10 p  0.001
sorLA-C (Alexa488) None 2059  18 6
sorLA-C (Alexa488) APP-C (Cy3) 1985  47 8 p  0.001
N, N-terminal; C, C-terminal.
Figure 7. Coimmunoprecipitation of BACE and sorLA. sorLA was immunoprecipitated and
probed for BACE by BACE antibody from transfected N2a cell extracts. A, Immunoreactive bands
of sorLA and BACE in lysates and pull-downs demonstrate BACE–sorLA interaction. B, Interac-
tion of sorLA and BACE could be proven when BACE was immunoprecipitated and sorLA was
shown to coimmunoprecipitate. Double bands of BACE show mature and immature form of
BACE. C, Coimmunoprecipitation of endogenous BACE and sorLA from mouse brain extract.
BACE was immunoprecipitated with rabbit N-terminal BACE antibody and probed for sorLA. D,
In the absence of the pull-down antibody, no immunoreactive band was detected for sorLA. IP,
Immunopreciptation; CoIP, coimmunopreciptation.
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BACE and APP interaction is disrupted by
sorLA primarily in the perinuclear region.
Because the reduced APP–BACE complex
formation in sorLA-overexpressing cells is
not attributable to altered levels of APP
and BACE or to a shift in the subcellular
distribution of BACE, we postulate that
sorLA might have a direct effect on BACE.
Our current study provides evidence for
the presence of a complex containing both
sorLA and BACE. When BACE and sorLA-
cotransfected cells or endogenous proteins
from mouse brain extracts were immuno-
precipitated, coimmunoprecipitation of
BACE using anti-sorLA antibodies and
sorLA using anti-BACE antibodies could
be demonstrated. Because we mainly ob-
serve an interaction between sorLA, APP,
and BACE in the perinuclear region, it
seems likely that sorLA particularly affects
APP processing and thereby A genera-
tion in the ER and Golgi apparatus. In fact,
A can be generated in the ER and Golgi
apparatus (Kuentzel et al., 1993; Chyung et
al., 1997; Cook et al., 1997; Hartmann et
al., 1997).
In conclusion, we envision a model in
which sorLA impacts APP -cleavage and
A production by influencing complex
formation between APP and BACE pre-
dominantly in the Golgi apparatus (Fig. 9,
schematic overview). According to this
model, sorLA mediates transport of APP
through the Golgi and, possibly by block-
ing access of BACE to APP, inhibits APP
-site cleavage. Because full-length sorLA
is more efficient than the sorLA
C-terminal tail in this respect, it is possible
that interactions between the luminal do-
main of sorLA and the luminal domain of
APP [demonstrated by Andersen et al.
(2005)] contribute to protecting it from
BACE cleavage. This model predicts that
sorLA-mediated retention of APP in the
Golgi and protection from BACE cleavage
plays an important regulatory role in de-
termining the amount of precursor that is
released into the later secretory pathway
for proteolytic processing into A.
Moreover, we also found evidence of an
interaction of sorLA with BACE. sorLA
and BACE mainly colocalized in the Golgi,
suggesting that sorLA also binds BACE in the Golgi and thereby
inhibits its access to APP. Although it is also possible that sorLA
contributes to retrograde transport of BACE to the Golgi, the
observation that sorLA coimmunoprecipitates principally with
nonglycosylated immature forms of BACE points to an interac-
tion in the Golgi.
The observations that sorLA is downregulated in AD brain
and that, in experimental systems, sorLA reduction and overex-
pression impact A production point to a pivotal role of sorLA in
AD pathophysiology (Andersen et al., 2005). Although the sor-
LA–APP interactions we report here have similarities to the in-
teraction of the LRP with APP, which also interacts through both
C-terminal and luminal domain interactions (Kinoshita et al.,
2003), the lack of effect of the NPXY mutant on APP–sorLA
interactions argue that the adaptor proteins mediating the inter-
action must be different from the NPXY motif interacting adap-
tor Fe65. The identity of these postulated adaptor proteins is
uncertain. For example, although GGA proteins are known to
interact with both BACE and sorLA (Jacobsen et al., 2002; Shiba
et al., 2004; von Arnim et al., 2004; He et al., 2005), GGA is
monomeric, and both interactions are believed to be mediated
via the VHS (Vps27, Hrs, and signal transducing adaptor mole-
Figure 8. Interaction of APP and BACE dependent on sorLA. For FLIM analysis of APP and BACE proximity, N2a cells were
transfected with BACE, BACE–APP, and BACE–APP–sorLA. BACE was labeled on the N-terminal domain by a BACE antibody
labeled by Alexa 488 and APP by N-terminal 8E5 antibody labeled by Cy3. A, In the absence of acceptor fluorophore Cy3, lifetime
averages at 2051  17 ps. B, C, BACE–APP-transfected cells show BACE–APP interaction mainly in the perinuclear region (B),
whereas the FRET interaction in cells that also expressed sorLA was strongly reduced (C). Intensity images of BACE–APP and
BACE–APP–sorLA-transfected cells revealed that the immunostaining pattern for BACE or APP is not significantly altered by sorLA.
Table 3. FLIM assay for BACE–APP interaction in N2a cells
Donor Acceptor sorLA
Lifetime (ps)
(mean  SD) n (cells)
Significance
(compared with control)
BACE (Alexa 488) None 2035  18 8
BACE (Alexa 488) APP-myc (Cy3) 1756  184 10 p  0.001
BACE (Alexa 488) APP-myc (Cy3) sorLA 2022  65 10 n.s.
BACE (Alexa 488) None 2051  17 9
BACE (Alexa 488) APP-myc (Cy3) 1939  59 9 p  0.001
BACE (Alexa 488) APP-myc (Cy3) sorLA 2027  28 12 n.s.
BACE (Alexa 488) None 1996  43 10
BACE (Alexa 488) APP-myc (Cy3) 1902  48 10 p  0.001
BACE (Alexa 488) APP-myc (Cy3) sorLA 2019  35 9 n.s
n.s., Nonsignificant.
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cule) domain, arguing against a mechanism through which GGA
interacts with both BACE and sorLA simultaneously. Additional
evaluation of the molecular mechanisms of sorLA–APP and sor-
LA–BACE interactions may lead to insight into APP processing
and its alterations in Alzheimers disease.
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